Position in NRIX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,985,726
+$1,073,538 QoQ
Shares Held
123,072
-0.2% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,721,264 across 329 Biotechnology names. NRIX ranks #75 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,985,726 | 123,072 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,912,188 | 123,367 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,249,804 | 118,598 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,057,222 | 114,418 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,426,335 | 125,227 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,312,597 | 110,488 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,944,909 | 103,233 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,042,927 | 90,918 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,852,859 | 88,781 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,143,233 | 77,771 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $775,104 | 75,107 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $589,885 | 75,049 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $729,829 | 73,056 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $646,570 | 72,812 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $777,021 | 70,767 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $913,272 | 70,090 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $798,704 | 63,039 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $469,489 | 33,511 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $924,605 | 31,938 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $930,977 | 31,074 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $791,018 | 29,816 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $752,844 | 24,215 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $382,164 | 11,623 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $332,098 | 9,513 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||